Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition
- PMID: 32209018
- PMCID: PMC7187969
- DOI: 10.1089/tmj.2020.0006
Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy, Third Edition
Abstract
Contributors The following document and appendices represent the third edition of the Practice Guidelines for Ocular Telehealth-Diabetic Retinopathy. These guidelines were developed by the Diabetic Retinopathy Telehealth Practice Guidelines Working Group. This working group consisted of a large number of subject matter experts in clinical applications for telehealth in ophthalmology. The editorial committee consisted of Mark B. Horton, OD, MD, who served as working group chair and Christopher J. Brady, MD, MHS, and Jerry Cavallerano, OD, PhD, who served as cochairs. The writing committees were separated into seven different categories. They are as follows: 1.Clinical/operational: Jerry Cavallerano, OD, PhD (Chair), Gail Barker, PhD, MBA, Christopher J. Brady, MD, MHS, Yao Liu, MD, MS, Siddarth Rathi, MD, MBA, Veeral Sheth, MD, MBA, Paolo Silva, MD, and Ingrid Zimmer-Galler, MD. 2.Equipment: Veeral Sheth, MD (Chair), Mark B. Horton, OD, MD, Siddarth Rathi, MD, MBA, Paolo Silva, MD, and Kristen Stebbins, MSPH. 3.Quality assurance: Mark B. Horton, OD, MD (Chair), Seema Garg, MD, PhD, Yao Liu, MD, MS, and Ingrid Zimmer-Galler, MD. 4.Glaucoma: Yao Liu, MD, MS (Chair) and Siddarth Rathi, MD, MBA. 5.Retinopathy of prematurity: Christopher J. Brady, MD, MHS (Chair) and Ingrid Zimmer-Galler, MD. 6.Age-related macular degeneration: Christopher J. Brady, MD, MHS (Chair) and Ingrid Zimmer-Galler, MD. 7.Autonomous and computer assisted detection, classification and diagnosis of diabetic retinopathy: Michael Abramoff, MD, PhD (Chair), Michael F. Chiang, MD, and Paolo Silva, MD.
Keywords: artificial intelligence; diabetic retinopathy; telehealth; telemedicine; teleophthalmology.
Conflict of interest statement
M.D.A. is founder, CEO, director of IDx (Coralville, IA), and an investor. M.D.A. has patent and patent applications assigned to the University of Iowa, to the Department of Veterans Affairs, and to IDx. T.L. is consultant for Spect, Inc. (San Francisco, CA). K.R. is chief medical officer of IBM, Inc. (Yorktown, NY). M.F.C. is an unpaid member of the Scientific Advisory Board for Clarity Medical Systems (Pleasanton, CA) and a consultant for Novartis (Basel, Switzerland). M.B.H. has no competing financial interests.
K.G. is the Ophthalmology Director of Care 1 Inc.; L.R.P. is a consultant to Verily, Eyenovia, Bausch + Lomb, Nicox and Emerald Bioscience.
J.P.C. receives grant support from Genentech, and is listed on a preliminary patent application related to deep learning technology for ROP screening.
No competing financial interests exist.
Figures



References
-
- Hogenbirk JC, Brockway PD, Finley J, et al. Framework for Canadian telehealth guidelines: Summary of the environmental scan. J Telemed Telecare 2006;12:64–70 - PubMed
-
- TeleSCoPE Project. European code of practice for telehealth services. 2014. Available at www.telehealthcode.eu/images/stories/telehea/pdf/TELESCOPE_2014_CODE_FIN... (last accessed December29, 2019)
-
- International Organization for Standardization. 2018. Available at www.iso.org (last accessed December29, 2019)
-
- American Telemedicine Association. Core operational guidelines for teleheatlh service involving provider-patient interactions. 2014. Available at thesource.americantelemed.org/resources/telemedicine-practice-guidelines (last accessed December29, 2019)
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical